Travel Vaccines Market by Disease Type (Covid-19, Ebola, Influenza, Hepatitis), Product (Hepatitis,

Travel Vaccines Market Synopsis
Global Travel Vaccines Market size was valued at USD 10.98 billion in 2022 and is projected to reach USD 21.64 Billion by 2030, growing at a CAGR of 8.85% from 2023 to 2030.

Travel vaccines, also known as travel immunizations or travel vaccinations, are vaccinations that individuals receive before traveling to certain regions or countries to protect them from specific diseases that may be prevalent in those areas. The goal is to prevent the spread of infectious diseases and protect both travellers and the local population.
The specific vaccines recommended or required for travel depend on various factors, including the destination, the duration of the trip, the traveller’s age, health status, and previous immunization history.
The necessity for travel vaccines arises because different regions of the world may have unique health risks and endemic diseases that are not prevalent in the traveller’s home country. Exposure to these diseases can lead to illness or infection, and in some cases, these diseases may have severe consequences.
Common travel vaccines protect against diseases such as yellow fever, typhoid, hepatitis A and B, meningitis, polio, Japanese encephalitis, rabies, and influenza. The choice of vaccines depends on various factors, including the traveller’s destination, the duration of stay, planned activities, and individual health considerations.